Drawing for DEFINITIVEDX

USPTO serial 86504155

DEFINITIVEDX

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
FRAZIER, TAMARA G
Law office
TMO LAW OFFICE 116 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with DEFINITIVEDX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
038Providing an on-line forum for healthcare professionals; Secure e-mail services; Web conferencing services; Web messagingACTIVE—
042Providing a web site featuring technology enabling physicians to access resources in clinical medicine; Providing a web site featuring technology that enables physicians to generate, manage and exchange medical information and documents regardless of medical organization or geographic locationACTIVE—
044Providing healthcare informationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Feb 8, 2017MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 8, 2017ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 1, 2016GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Jul 1, 2016GNSIINQUIRY TO SUSPENSION E-MAILED—
Jul 1, 2016CNSISUSPENSION INQUIRY WRITTEN—
Jun 13, 2016RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Dec 5, 2015GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Dec 5, 2015GNSLLETTER OF SUSPENSION E-MAILED—
Dec 5, 2015CNSLSUSPENSION LETTER WRITTEN—
Nov 24, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 24, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 23, 2015ALIEASSIGNED TO LIE—
Nov 4, 2015ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Nov 3, 2015GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Nov 3, 2015GNSIINQUIRY TO SUSPENSION E-MAILED—
Nov 3, 2015CNSISUSPENSION INQUIRY WRITTEN—
Apr 28, 2015GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Apr 28, 2015GNSLLETTER OF SUSPENSION E-MAILED—
Apr 28, 2015CNSLSUSPENSION LETTER WRITTEN—
Apr 21, 2015DOCKASSIGNED TO EXAMINER—
Jan 29, 2015MPMKNOTICE OF PSEUDO MARK E-MAILED—
Jan 28, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 19, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance